Fast reading
- Employing more than 15,000 people across 58 countries, Ansell’s products are sold in over 100 countries and across 25 industries. Within healthcare, its portfolio covers surgical gloves, single-use and examination gloves and products for those working within life-science companies. Within its industrials portfolio, the company provides high-performance safety gloves and chemical-protection clothing for workers across a wide range of industries including automotives, and oil and gas.
- Ansell has a diversified revenue base across end markets and regions with significant further growth opportunities as regulators enforce more stringent rules around worker safety and protection.
- The company is highly cashflow generative with strong cash conversion. As a result, it is able to invest in manufacturing capacity while also engaging in M&A (most recently in clean-room protection) and simultaneously providing returns to shareholders.
SDG Engagement Equity, Q4 2024 case study
Share:
BD015130
